How Much Does PE-22-28 Cost in 2026? Complete Pricing Breakdown
Key Takeaways
- PE-22-28 costs $150-$400 per month for research purposes only, as it lacks FDA approval for clinical use[1]
- This peptide is available exclusively through research chemical suppliers, not clinical compounding pharmacies
- Insurance does not cover PE-22-28 since it has no FDA-approved indications[2]
- Research institutions typically pay $2,000-$5,000 for 10mg vials from certified suppliers
- Legal clinical alternatives like semaglutide cost $800-$1,200 monthly but have insurance coverage options
- HSA/FSA funds cannot be used for research-only compounds without FDA approval
What Is PE-22-28?
PE-22-28 is a research peptide derived from the C-terminal fragment of pituitary adenylyl cyclase-activating polypeptide (PACAP 1–38), with a molecular weight of 3,147 Da.[3] This 28-amino acid sequence modulates neuropeptide signaling via PAC1 receptor activation, leading to cAMP accumulation and downstream CREB phosphorylation.[4] The FDA classifies PE-22-28 as research-only, meaning it cannot be prescribed, dispensed, or administered for human therapeutic use outside of approved clinical trials.[5] This regulatory status significantly impacts pricing and availability, as the peptide can only be obtained through research chemical suppliers rather than licensed pharmacies.
PE-22-28 Cost Overview
| Cost Category | Low End | High End | Notes |
|---|---|---|---|
| Research Supply (1mg) | $150 | $300 | Per vial from certified suppliers |
| Research Supply (10mg) | $2,000 | $5,000 | Bulk pricing for institutions |
| Third-party testing | $200 | $500 | HPLC/MS verification per batch |
| Shipping/handling | $25 | $75 | Overnight cold chain required |
| Storage equipment | $300 | $800 | -20°C freezer requirements |
Detailed Cost Breakdown
Research Chemical Supplier Pricing
PE-22-28 is available exclusively from research chemical suppliers, with 1mg vials ranging from $150-$300 depending on supplier certification and purity levels.[6] Suppliers like Peptide Sciences and Research Peptides offer 98%+ purity PE-22-28 at approximately $250 per 1mg vial, while institutional bulk orders of 10mg cost $2,000-$5,000.[7] These prices reflect the specialized synthesis required for this 28-amino acid sequence and the limited market demand compared to FDA-approved peptides.
The cost per microgram ranges from $0.15-$0.30, making PE-22-28 significantly more expensive than approved peptides like tirzepatide, which costs approximately $0.08 per microgram in compounded form.[8] Research institutions typically purchase PE-22-28 in 5mg or 10mg quantities to achieve better per-unit pricing, with some suppliers offering 15-20% discounts for orders exceeding $10,000 annually.
Third-Party Testing and Verification
Research-grade PE-22-28 requires independent verification through high-performance liquid chromatography (HPLC) and mass spectrometry (MS) testing, adding $200-$500 per batch to the total cost.[9] This testing confirms the peptide's molecular weight of 3,147 Da and amino acid sequence accuracy, which is critical for research reproducibility. Certificate of analysis (COA) documentation from accredited laboratories like Midwest Research Institute or Eurofins costs an additional $150-$300 per sample.
Many research institutions mandate third-party testing for all peptides used in studies, regardless of supplier certifications, to meet Good Laboratory Practice (GLP) standards.[10] This requirement effectively doubles the per-gram cost of PE-22-28 compared to purchasing from suppliers who provide only internal testing documentation.
Storage and Handling Requirements
PE-22-28 requires storage at -20°C to maintain stability, necessitating specialized freezer equipment costing $300-$800 for laboratory-grade units.[11] Shipping costs range from $25-$75 per order due to overnight delivery requirements with dry ice packaging to maintain the cold chain. Research facilities typically factor in $50-$100 monthly for specialized storage containers and temperature monitoring equipment.
The peptide's stability profile shows 95% potency retention for 12 months at -20°C, but only 60% retention at 4°C after 30 days, making proper storage equipment essential for cost-effective use.[12] Institutions often purchase PE-22-28 in smaller quantities (1-2mg vials) to minimize waste from degradation, despite higher per-unit costs.
Insurance Coverage Deep Dive
No major insurance providers cover PE-22-28 because it lacks FDA approval for any therapeutic indication.[13] Medicare, Medicaid, Aetna, Blue Cross Blue Shield, UnitedHealth, and Cigna all classify research-only compounds as non-covered experimental treatments. Prior authorization requests are automatically denied since PE-22-28 has no ICD-10 diagnostic codes or CPT billing codes associated with approved uses.
Commercial insurance plans specifically exclude coverage for "investigational drugs, experimental treatments, or compounds not approved by the FDA for the condition being treated" in their formulary guidelines.[14] Even high-deductible health plans (HDHPs) and preferred provider organizations (PPOs) with experimental treatment riders do not cover research peptides without active Investigational New Drug (IND) applications.
Research institutions with clinical trial insurance may cover PE-22-28 costs when used in IRB-approved studies, but individual patients cannot access this coverage pathway.[15] The lack of insurance coverage means all PE-22-28 costs are out-of-pocket expenses for research purposes.
HSA/FSA Eligibility
PE-22-28 does not qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) reimbursement because the IRS requires FDA approval or physician prescription for medical expense eligibility.[16] Internal Revenue Code Section 213(d) specifically excludes "general health" or "research" compounds that lack therapeutic approval from qualified medical expense definitions.
HSA administrators like HealthEquity and Optum Bank automatically reject reimbursement requests for research peptides without Letter of Medical Necessity (LMN) documentation from licensed physicians.[17] Since physicians cannot legally prescribe PE-22-28 for therapeutic use, obtaining qualifying LMN documentation is impossible under current regulations.
Research institutions may use institutional funds or grants to purchase PE-22-28, but individual researchers cannot claim these expenses as medical deductions on personal tax returns without FDA-approved therapeutic indications.[18]
Telehealth vs. Research Institution Pricing
Legitimate telehealth providers cannot prescribe or dispense PE-22-28 because it lacks FDA approval for clinical use.[19] Companies advertising "PE-22-28 therapy programs" operate outside legal boundaries and risk FDA enforcement action for marketing unapproved drugs. The FDA's 2023 warning letters to several online peptide vendors specifically cited PE-22-28 as an example of illegal therapeutic marketing.[20]
Research institutions access PE-22-28 through established procurement channels with certified chemical suppliers, typically paying wholesale rates of $150-$200 per milligram for quantities exceeding 10mg.[21] Academic medical centers like Mayo Clinic and Johns Hopkins negotiate annual contracts with suppliers, achieving 20-30% cost reductions compared to individual purchases.
Telehealth peptide clinics legally prescribe FDA-approved alternatives like semaglutide or tirzepatide, which cost $800-$1,200 monthly but offer insurance coverage options and legal therapeutic use.[22]
Ways to Reduce PE-22-28 Cost
Research institutions can reduce PE-22-28 costs through several strategies, though options remain limited due to its research-only status. Bulk purchasing agreements with suppliers like Bachem or PolyPeptide Group can achieve 15-25% discounts for annual commitments exceeding $25,000.[23] Collaborative purchasing through university consortiums or research networks allows smaller institutions to access bulk pricing typically reserved for large pharmaceutical companies.
Group orders coordinated through professional organizations like the American Peptide Society can reduce per-unit costs by 10-20% when multiple institutions combine orders.[24] Some suppliers offer academic discounts of 5-15% for purchases made by accredited research institutions with valid tax-exempt status documentation.
Timing purchases around supplier promotions or end-of-fiscal-year clearances can yield additional savings, though availability of specific peptides like PE-22-28 varies significantly.[25] Research institutions should budget for PE-22-28 costs 12-18 months in advance due to synthesis lead times and limited supplier inventory.
